Abano Appoints Australian Director
Abano Healthcare Group (NZX:ABA) has today announced the appointment of Mr Murray Boyte as an independent director.
Mr Boyte had a successful career in New Zealand before moving to Australia where he now resides. Since 2002, he has been the chief executive officer of Ariadne Australia Limited, an ASX-listed investment company with a diversified investment strategy and operations in Australia and New Zealand.
Murray has held a number of governance positions in the transport, financial services, investment and health services industries. He has a sound understanding of the Australian and New Zealand investment market and regulatory framework, as well as extensive trans-Tasman commercial experience.
Chairman of Abano, Mr Trevor Janes, said: “Towards the end of 2014, the Abano Board undertook a review to consider the appropriate skills which we believed would add value to Abano as we continue to implement our growth strategy. In particular, as our Australian businesses become an increasingly important part of our strategy and generate over 50% of our gross revenue, we believed it was important for us to have an Australian-based director.
“Murray’s career spans more than 35 years and he has been involved in the growth and evolution of companies in Australia, New Zealand, North America and Hong Kong. He has considerable operating and strategic experience in the Australian marketplace, which will be of value to Abano as we continue to grow our Australian businesses”.
Mr Boyte has been appointed to the Abano Board by the current Abano directors, as permitted under Abano’s constitution. He will hold office until Abano’s 2015 annual meeting at which time he will offer himself for election by shareholders. The Board has determined that Mr Boyte is an independent director, for the purposes of NZX Listing Rule 3.3.2.